Genpharmasec Limited (BOM:531592)
India · Delayed Price · Currency is INR 1.250
+0.090 (7.76%)
At close: Jan 22, 2026
Genpharmasec Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 2.39 | 12.31 | -1.69 | 11.25 | -2.09 | 12.57 | Upgrade |
Depreciation & Amortization | 11.75 | 8.12 | 0.42 | 0.2 | 0.14 | 0.13 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | - | 0.09 | - | Upgrade |
Provision & Write-off of Bad Debts | 4.48 | 3.94 | 4.27 | 1.75 | - | - | Upgrade |
Other Operating Activities | -22 | -16.69 | 2.95 | -6.1 | -3.3 | -4.26 | Upgrade |
Change in Accounts Receivable | -183.19 | -48.9 | -33.91 | 7.39 | 10.77 | -4.92 | Upgrade |
Change in Inventory | -87.73 | 6.45 | 8.33 | 2.13 | -22.08 | -42.21 | Upgrade |
Change in Accounts Payable | 344.42 | 58.8 | 10.09 | -48.51 | -8.95 | 15.74 | Upgrade |
Change in Other Net Operating Assets | 27.85 | 5.84 | -19.92 | 1.29 | 1.98 | 1.6 | Upgrade |
Operating Cash Flow | 97.96 | 29.87 | -29.46 | -30.6 | -23.44 | -21.35 | Upgrade |
Capital Expenditures | -21.46 | -57.05 | -0.18 | -0.16 | -0.81 | -0.13 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 0.02 | - | Upgrade |
Investment in Securities | 0.45 | - | -176.4 | 3.33 | 2.73 | -62.32 | Upgrade |
Other Investing Activities | 10.63 | 22.83 | 4.73 | 0.23 | 0.66 | 3.27 | Upgrade |
Investing Cash Flow | -86.62 | -152.98 | -280.63 | 3.63 | 4.18 | -14.1 | Upgrade |
Long-Term Debt Issued | - | - | 54.8 | 30.4 | - | - | Upgrade |
Long-Term Debt Repaid | - | -6.23 | -57.64 | - | - | - | Upgrade |
Net Debt Issued (Repaid) | 1.66 | -6.23 | -2.84 | 30.4 | - | - | Upgrade |
Issuance of Common Stock | - | - | 484.51 | - | - | 45 | Upgrade |
Other Financing Activities | -7.74 | -6.26 | -3.2 | 0.42 | - | - | Upgrade |
Financing Cash Flow | -6.07 | -12.49 | 478.47 | 30.82 | - | 45 | Upgrade |
Miscellaneous Cash Flow Adjustments | 6.92 | 0 | - | - | - | - | Upgrade |
Net Cash Flow | 12.19 | -135.6 | 168.38 | 3.85 | -19.26 | 9.55 | Upgrade |
Free Cash Flow | 76.5 | -27.19 | -29.64 | -30.76 | -24.25 | -21.47 | Upgrade |
Free Cash Flow Margin | 11.39% | -8.06% | -9.75% | -12.05% | -8.88% | -10.08% | Upgrade |
Free Cash Flow Per Share | 0.13 | -0.05 | -0.10 | -0.11 | -0.09 | -0.08 | Upgrade |
Cash Interest Paid | 7.74 | 6.26 | 3.75 | - | - | - | Upgrade |
Cash Income Tax Paid | 14.56 | 0.74 | 0.41 | -2.55 | 0.3 | 3.51 | Upgrade |
Levered Free Cash Flow | 72.18 | -9.09 | -29.15 | -43.65 | -44.21 | 7.35 | Upgrade |
Unlevered Free Cash Flow | 76 | -6.37 | -26.59 | -43.3 | -44.21 | 7.35 | Upgrade |
Change in Working Capital | 101.34 | 22.18 | -35.41 | -37.69 | -18.28 | -29.79 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.